Emergent pericardiocentesis in SARS-CoV-2 myocardiopericarditis.
DOI:
https://doi.org/10.30445/rear.v14i11.1113Keywords:
Viral myocardiopericarditis, cardiac tamponade, emergent pericardiocentesis, transthoracic echocardiography, cardiac magnetic resonanceAbstract
Cardiovascular complications caused by the SARS-CoV-2 virus are associated with high morbidity and mortality. Its early diagnosis can be decisive in the patient's prognosis.
We present the case of a patient admitted to the critical care unit for a severe SARS-CoV-2 infection. During admission, she suffered a cardiac arrest caused by cardiac tamponade diagnosed by transthoracic echocardiography, which required an emergent pericardiocentesis. Cardiac magnetic resonance imaging was consistent with viral myocardiopericarditis. Myocardiopericarditis and cardiac tamponade are cardiovascular complications caused by the SARS-CoV-2 virus. Transthoracic ultrasound is a decisive tool in its early diagnosis. Its routine use in critical care units is crucial in the management of these patients.
References
- Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015;28(1):1-39.e14. doi:10.1016/j.echo.2014.10.003
- Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2002;15(2):167-184. doi:10.1067/mje.2002.120202
- Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. European Heart Journal. 2015;36(42):2921-2964. doi:10.1093/eurheartj/ehv318
- Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine. 2020;8(4):420-422. doi:10.1016/S2213-2600(20)30076-X
- Dhakal BP, Sweitzer NK, Indik JH, Acharya D, William P. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart, Lung and Circulation. 2020;29(7):973-987. doi:10.1016/j.hlc.2020.05.101
- Kariyanna PT, Sutarjono B, Grewal E, et al. A Systematic Review of COVID-19 and Myocarditis. Am J Med Case Rep. 2020;8(9):299-305.
- Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17(9):1439-1444. doi:10.1016/j.hrthm.2020.06.016
- Hayek SS, Brenner SK, Azam TU, et al. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ. Published online September 30, 2020:m3513. doi:10.1136/bmj.m3513
- Shao F, Xu S, Ma X, et al. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation. 2020;151:18-23. doi:10.1016/j.resuscitation.2020.04.005
- Mester A, Benedek I, Rat N, Tolescu C, Polexa SA, Benedek T. Imaging Cardiovascular Inflammation in the COVID-19 Era. Diagnostics. 2021;11(6):1114. doi:10.3390/diagnostics11061114
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Electrónica AnestesiaR
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Envío y derechos de autor
Revista Electrónica AnestesiaR by 